(Q37602130)

21 August 2017

1 reference

title

Crosstalk between calcium, amyloid beta and the receptor for advanced glycation endproducts in Alzheimer's disease (English)

1 reference

21 August 2017

0 references

2

Emmanuel Sturchler

0 references

author name string

Estelle Leclerc

series ordinal

1

1 reference

PubMed ID

19774788

21 August 2017

Stefan W Vetter

series ordinal

3

1 reference

PubMed ID

19774788

21 August 2017

Claus W Heizmann

series ordinal

4

1 reference

21 August 2017

1 January 2009

1 reference

Reviews in the Neurosciences

21 August 2017

1 reference

21 August 2017

20

1 reference

21 August 2017

2

1 reference

21 August 2017

95-110

1 reference

Expression of MRP14, 27E10, interferon-alpha and leukocyte common antigen by reactive microglia in postmortem human brain tissue.

21 August 2017

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

RAGE potentiates Abeta-induced perturbation of neuronal function in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

Giant multilevel cation channels formed by Alzheimer disease amyloid beta-protein [A beta P-(1-40)] in bilayer membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

The Alzheimer disease-related calcium-binding protein Calmyrin is present in human forebrain with an altered distribution in Alzheimer's as compared to normal ageing brains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

S100A8 and S100A9 mediate endotoxin-induced cardiomyocyte dysfunction via the receptor for advanced glycation end products

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

S100B protects LAN-5 neuroblastoma cells against Abeta amyloid-induced neurotoxicity via RAGE engagement at low doses but increases Abeta amyloid neurotoxicity at high doses

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

A role for calsenilin and related proteins in multiple aspects of neuronal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

Transthyretin protects Alzheimer's mice from the behavioral and biochemical effects of Abeta toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

Beta-amyloid inhibits integrated mitochondrial respiration and key enzyme activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

Toll-like receptor 4 is involved in subacute stress-induced neuroinflammation and in the worsening of experimental stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

The pattern recognition receptor (RAGE) is a counterreceptor for leukocyte integrins: a novel pathway for inflammatory cell recruitment

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

The role of amyloid precursor protein processing by BACE1, the beta-secretase, in Alzheimer disease pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

Enhanced susceptibility of S-100B transgenic mice to neuroinflammation and neuronal dysfunction induced by intracerebroventricular infusion of human beta-amyloid

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

Alzheimer's disease amyloid-beta binds copper and zinc to generate an allosterically ordered membrane-penetrating structure containing superoxide dismutase-like subunits

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

Oligomeric and fibrillar species of amyloid-beta peptides differentially affect neuronal viability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

Intracellular Ca2+ and Zn2+ levels regulate the alternative cell density-dependent secretion of S100B in human glioblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

Glycation and microglial reaction in lesions of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

Splice variants of the receptor for advanced glycosylation end products (RAGE) in human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

Intracellular and extracellular roles of S100 proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

RAGE: a single receptor for several ligands and different cellular responses: the case of certain S100 proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

Amyloid-beta peptide-receptor for advanced glycation endproduct interaction elicits neuronal expression of macrophage-colony stimulating factor: a proinflammatory pathway in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

Enhanced epileptogenesis in S100B knockout mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

Circulating levels of soluble receptor for advanced glycation end products in Alzheimer disease and vascular dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

S100B induces tau protein hyperphosphorylation via Dickopff-1 up-regulation and disrupts the Wnt pathway in human neural stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

S100 proteins expressed in phagocytes: a novel group of damage-associated molecular pattern molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

Calcium-regulated intramembrane proteolysis of the RAGE receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

Beta-amyloid peptide potentiates inflammatory responses induced by lipopolysaccharide, interferon -gamma and 'advanced glycation endproducts' in a murine microglia cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

S100A8/A9 at low concentration promotes tumor cell growth via RAGE ligation and MAP kinase-dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

Structures and metal-ion-binding properties of the Ca2+-binding helix-loop-helix EF-hand motifs

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

Amyloid beta peptides mediate hypoxic augmentation of Ca(2+) channels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

Calbindin D28k blocks the proapoptotic actions of mutant presenilin 1: reduced oxidative stress and preserved mitochondrial function

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

Amyloid beta-peptide is produced by cultured cells during normal metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

Overexpression of receptor of advanced glycation end products hypersensitizes cells for amyloid beta peptide-induced cell death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

Alzheimer's disease: the amyloid cascade hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

Microglial dysfunction and defective beta-amyloid clearance pathways in aging Alzheimer's disease mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

Transthyretin oligomers induce calcium influx via voltage-gated calcium channels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

Alternate aggregation pathways of the Alzheimer beta-amyloid peptide. An in vitro model of preamyloid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

Identification, classification, and expression of RAGE gene splice variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

Interaction of the RAGE cytoplasmic domain with diaphanous-1 is required for ligand-stimulated cellular migration through activation of Rac1 and Cdc42

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

Role of formyl peptide receptor-like 1 (FPRL1/FPR2) in mononuclear phagocyte responses in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

The receptor for advanced glycation end-products (RAGE) directly binds to ERK by a D-domain-like docking site

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

Antagonist of the amylin receptor blocks beta-amyloid toxicity in rat cholinergic basal forebrain neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

The channel hypothesis of Alzheimer's disease: current status

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

Specific citrullination causes assembly of a globular S100A3 homotetramer: a putative Ca2+ modulator matures human hair cuticle

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

Abeta toxicity in Alzheimer's disease: globular oligomers (ADDLs) as new vaccine and drug targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

S100B potently activates p65/c-Rel transcriptional complexes in hippocampal neurons: Clinical implications for the role of S100B in excitotoxic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

Intracellular amyloid-beta in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

Neurodegenerative disease: amyloid pores from pathogenic mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

S100B and S100A6 differentially modulate cell survival by interacting with distinct RAGE (receptor for advanced glycation end products) immunoglobulin domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

The AbetaCs of Abeta-cleaving proteases

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

Calcium-dependent tetramer formation of S100A8 and S100A9 is essential for biological activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

Selective changes of calcineurin (protein phosphatase 2B) activity in Alzheimer's disease cerebral cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

Expression of human beta-amyloid peptide in transgenic Caenorhabditis elegans

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

Copper, iron and zinc in Alzheimer's disease senile plaques.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

Involvement of microglial receptor for advanced glycation endproducts (RAGE) in Alzheimer's disease: identification of a cellular activation mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

cDNA cloning of a novel secreted isoform of the human receptor for advanced glycation end products and characterization of cells co-expressing cell-surface scavenger receptors and Swedish mutant amyloid precursor protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

S100 proteins in mouse and man: from evolution to function and pathology (including an update of the nomenclature)

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

An update of the S100 nomenclature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

Increased S100 beta neurotrophic activity in Alzheimer's disease temporal lobe

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

Neuronal and glial calcium signaling in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

Hippocampal RAGE immunoreactivity in early and advanced Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

Memantine improves spatial learning in a transgenic mouse model of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

Multiple structural states of S100A12: A key to its functional diversity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

The role of activated astrocytes and of the neurotrophic cytokine S100B in the pathogenesis of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

The induction of surface beta-amyloid binding proteins and enhanced cytotoxicity in cultured PC-12 and IMR-32 cells by advanced glycation end products

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

Molecular biology of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

Reduced expression of endogenous secretory receptor for advanced glycation endproducts in hippocampal neurons of Alzheimer's disease brains

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

Altered intracellular signaling and reduced viability of Alzheimer's disease neuronal cybrids is reproduced by beta-amyloid peptide acting through receptor for advanced glycation end products (RAGE).

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

Receptor for advanced glycation end product-dependent activation of p38 mitogen-activated protein kinase contributes to amyloid-beta-mediated cortical synaptic dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

Structural and functional insights into RAGE activation by multimeric S100B

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

Strain-specified relative conformational stability of the scrapie prion protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

RAGE recycles at the plasma membrane in S100B secretory vesicles and promotes Schwann cells morphological changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

Cerebrospinal fluid S100B is elevated in the earlier stages of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

Self-propagating, molecular-level polymorphism in Alzheimer's beta-amyloid fibrils

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

Autocrine S100B effects on astrocytes are mediated via RAGE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

Amyloid ion channels: a common structural link for protein-misfolding disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

Memantine in moderate-to-severe Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

S100B in brain damage and neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

Calcium-dependent and -independent interactions of the S100 protein family.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

Advanced glycation end products in Alzheimer's disease and other neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

Advanced glycation end products (AGE) and their receptor (RAGE) in the brain of patients with Creutzfeldt-Jakob disease with prion plaques.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

Calcium, troponin, calmodulin, S100 proteins: from myocardial basics to new therapeutic strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

RAGE: a multiligand receptor contributing to the cellular response in diabetic vasculopathy and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

The biology of the receptor for advanced glycation end products and its ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

'New' functions for 'old' proteins: the role of the calcium-binding proteins calbindin D-28k, calretinin and parvalbumin, in cerebellar physiology. Studies with knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

Amyloidogenic and anti-amyloidogenic properties of recombinant transthyretin variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

Isolation and quantification of soluble Alzheimer's beta-peptide from biological fluids

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

Internalization of the receptor for advanced glycation end products (RAGE) is required to mediate intracellular responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

Production of the Alzheimer amyloid beta protein by normal proteolytic processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

Advanced Maillard reaction end products are associated with Alzheimer disease pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

Regulation of NMDA receptor trafficking by amyloid-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

N -Glycans on the receptor for advanced glycation end products influence amphoterin binding and neurite outgrowth

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

Neutralization of transthyretin reverses the neuroprotective effects of secreted amyloid precursor protein (APP) in APPSW mice resulting in tau phosphorylation and loss of hippocampal neurons: support for the amyloid hypothesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

Site-specific blockade of RAGE-Vd prevents amyloid-beta oligomer neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

Three genes in the human MHC class III region near the junction with the class II: gene for receptor of advanced glycosylation end products, PBX2 homeobox gene and a notch homolog, human counterpart of mouse mammary tumor gene int-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

Missorting of tau in neurons causes degeneration of synapses that can be rescued by the kinase MARK2/Par-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

Amyloid precursor protein trafficking, processing, and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

beta-Amyloid-mediated vasoactivity and vascular endothelial damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

Inhibition of calpains improves memory and synaptic transmission in a mouse model of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

A novel calcium-binding protein is associated with tau proteins in tauopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

Amyloid-beta oligomers: their production, toxicity and therapeutic inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

A primer of amyloid nomenclature

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

Expression and purification of recombinant human receptor for advanced glycation endproducts in Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

Nucleation-dependent polymerization is an essential component of amyloid-mediated neuronal cell death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

The role of calmodulin as a signal integrator for synaptic plasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

Structural basis for pattern recognition by the receptor for advanced glycation end products (RAGE).

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

Distribution of a specific calcium-binding protein of the S100 protein family, S100A6 (calcyclin), in subpopulations of neurons and glial cells of the adult rat nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

Apolipoprotein E and low density lipoprotein receptor-related protein facilitate intraneuronal Abeta42 accumulation in amyloid model mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

Receptor for advanced glycation end products is subjected to protein ectodomain shedding by metalloproteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

Neuronal Ca2+ sensor VILIP-1 leads to the upregulation of functional alpha4beta2 nicotinic acetylcholine receptors in hippocampal neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

Molecular mechanisms of S100-target protein interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

Receptor for Advanced Glycation End Products Activation Injures Primary Sensory Neurons via Oxidative Stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

Astrocytic calcium/zinc binding protein S100A6 over expression in Alzheimer's disease and in PS1/APP transgenic mice models

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

S100A6, a calcium- and zinc-binding protein, is overexpressed in SOD1 mutant mice, a model for amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2009.20.2.95

10.1515/REVNEURO.2009.20.2.95

21 January 2018

Identifiers

DOI

1 reference

21 August 2017

1 reference

PubMed ID

19774788